MEDLINE MAXORB EXTRA ALGINATE WOUND DRESSING 4X4 SQUARE REF MSC7044EP MEDLINE MOXORB EXTRA ALBIN...

FDA Device Recall #Z-0619-2025 — Class II — October 1, 2024

Recall Summary

Recall Number Z-0619-2025
Classification Class II — Moderate risk
Date Initiated October 1, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Advanced Medical Solutions Ltd.
Location Winsford
Product Type Devices
Quantity 1,800 boxes

Product Description

MEDLINE MAXORB EXTRA ALGINATE WOUND DRESSING 4X4 SQUARE REF MSC7044EP MEDLINE MOXORB EXTRA ALBINATE WOUND DRESSING 4X8 RECTANLE REF MSC7048EP Wound dressing indicated for moderate to heavily exuding chronic and acute wounds, and to control minor bleeding in superficial wounds.

Reason for Recall

Due to defects on primary packaging pouch that compromise the device's ability to maintain a sterile barrier.

Distribution Pattern

U.S. Nationwide distribution in the states of IL, TX, and VA.

Lot / Code Information

Model Number: MSC7044EP UDI-DI code: 10080196296842 Lot Number: W00070789 Model Number: MSC7048EP UDI-DI code: 10080196296828 Lot Number: W00070988

Other Recalls from Advanced Medical Solutions Ltd.

Recall # Classification Product Date
Z-0617-2025 Class II Hollister CalciCare Calcium Alginate Dressing R... Oct 1, 2024
Z-0618-2025 Class II McKesson Calcium Alginate Dressing MFR# 3562 ... Oct 1, 2024
Z-2719-2016 Class II ReliaMed¿ Silver Alginate/CMC. Each dressing is... Jan 15, 2015
Z-2720-2016 Class II ReliaMed¿ Alginate/CMC. Each dressing is packe... Jan 15, 2015

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.